ArticleFrontiers in immunology2022

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies.

Roberto Alfonso-Dunn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.